Covid | RxISK

Dennis the Menace gets Covid

February 26, 2021 | 30 Comments

Last March when the world was locking down for the first time in response to Covid, Joan-Ramon Laporte primarily, with me tagging along, wrote a short piece on polypharmacy as a possible hazard for older people, especially those in residential or care homes. Everybody was looking for the drug that might provide a miracle cure […]

Read more ....

Colchicine and Covid and Google

January 25, 2021 | 5 Comments

Perhaps linked to this January 23rd news: MONTREAL — A team of researchers from the Montreal Heart Institute believe they have found an effective weapon against COVID-19: colchicine, an oral tablet already known and used for other diseases. Full Article HERE We had an enquiry from a reader – can we let him know the […]

Read more ....

Report Covid Vaccine Effects to RxISK

January 11, 2021 | 28 Comments

This post asks anyone taking any Covid vaccine to report to RxISK using a RxISK Report if an event or condition occurs soon or some time after a jab that might be linked to the jab. You will need to specify just which vaccine you have been given and the dates of the first and […]

Read more ....

Starship Corona: Captain’s Log

April 26, 2020 | 22 Comments

The use of psychiatric meds in the U.S., already sky-high, is on the rise as a result of Covid-19. That’s not surprising – it happened after the 9-11 attacks, the 2008 crash and other crises. This graph comes from “America’s State of Mind,” an April 2020 report from Express Scripts. In the month from February […]

Read more ....

Covid and the Market in Research

April 13, 2020 | 20 Comments

There are 3 bits to this post – an interview with Joan-Ramon Laporte. An article by Ariane Denoyel and a Q and A with Laporte and Healy. Laporte Interview As part of a series for ROAR Magazine, Frank Barat has run some striking interviews about aspects of the Covid pandemic not usually mentioned. Here […]

Read more ....

Medications compromising Covid Infections

April 2, 2020 | 73 Comments

IN THE MIDST OF THE SARS-CoV-2 PANDEMIA, CAUTION IS NEEDED WITH COMMONLY USED DRUGS THAT INCREASE THE RISK OF PNEUMONIA. Joan-Ramon Laporte, M.D. Emeritus Professor of Clinical Pharmacology, Department of Pharmacology, Therapeutics and Toxicology Universitat Autònoma de Barcelona. Fundació Institut Català de Farmacologia. WHO Collaborating Centre for Research and Training in Pharmacoepidemiology. jrl@icf.uab.cat David Healy […]

Read more ....